Genzyme Pharmaceuticals, a business unit of Genzyme Corporation, provides over 25 years of experience to pharmaceutical and biotechnology companies in the area of custom manufacturing complex pharmaceutical materials and specialty chemicals. Our approach to the custom manufacturing market starts at early R&D phase and continues through to the development and commercialization of our customer’s drug product.
With a cGMP manufacturing facility located in Liestal, Switzerland, our products and services include registered intermediates, APIs, specialty chemicals, and materials used in delivering the active drug substance.
Our corporate infrastructure allows for the flexible autonomy of a distinct business within the stability of a premier biotechnology corporation. We extend this unequaled value in custom manufacturing to customers through an integrated resource of:
25% of staff have advanced degrees in science
Amino acid derivatives & building blocks
Synthetic phospholipids & other lipids
R&D and kilo lab facilities to support early stage chemical development
Production capacities from small kilo to ton quantities
Flexible equipment to suit short and long term development
FDA inspected plant for API s
Full analytical and regulatory services